- Report
- June 2024
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- October 2024
- 164 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- May 2024
- 83 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- February 2019
- 183 Pages
United States
From €4040EUR$4,250USD£3,394GBP
Point-of-Care (POC) Diagnostics is a rapidly growing field of medical technology that enables healthcare professionals to diagnose and treat patients in a variety of settings. POC Analyzers are a type of medical device used to detect and measure a variety of analytes, such as glucose, cholesterol, and electrolytes, in a patient’s blood or urine sample. These devices are designed to provide quick and accurate results, allowing healthcare professionals to make timely decisions about patient care.
The POC Analyzer market is driven by the need for rapid and accurate diagnosis in a variety of settings, including hospitals, clinics, and home care. The market is also driven by the increasing demand for cost-effective and efficient healthcare solutions. The market is expected to continue to grow as more healthcare providers adopt POC Analyzers to improve patient care.
Some companies in the POC Analyzer market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Alere. Show Less Read more